Evogene plans to attend BIO-Europe and Drug Discovery Chemistry Europe

EVGN•2026-10-26

Evogene plans to attend BIO-Europe in Cologne on Nov. 9-11, 2026, and Drug Discovery Chemistry Europe in Barcelona on Nov. 10-12, where it will present a scientific poster on its ChemPass AI platform.

1. Conference plans

Evogene plans to attend BIO-Europe in Cologne, Germany, from Nov. 9-11, 2026, to explore partnerships in AI-driven small-molecule discovery. It will also attend Drug Discovery Chemistry Europe in Barcelona, Spain, from Nov. 10-12, and present a scientific poster showcasing its ChemPass AI platform for small-molecule discovery and optimization.

Evogene plans to attend BIO-Europe and Drug Discovery Chemistry Europe

1. Conference plans

Related News

Alberta Securities Commission dismisses Curaleaf bid to halt Aurora Cannabis share-sale program

Slide Insurance expands into Texas and Rhode Island

US retail asking rent growth slows to 1.6% in Q3, lowest since 2017, CoStar says

Nice earnings forecasts you have. Shame if something happened to them: Joachim Klement

Savers Value Village plans Innovation Day for investors and analysts